ARIEL3: A phase 3, randomized, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian cancer (OC). Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Coleman, Robert L., Oza, Amit M., Lorusso, Domenica, Aghajanian, Carol, Oaknin, Ana, Dean, Andrew, Colombo, Nicoletta, Weberpals, Johanne I., Clamp, Andrew, Scambia, Giovanni, Leary, Alexandra, Holloway, Robert W., O'Malley, David M., Cameron, Terri, Maloney, Lara, Goble, Sandra, Lin, Kevin, Sun, James, Giordano, Heidi, Ledermann, Jonathan A.

authors

Publication Date

  • August 1, 2018

webpage

published in

category

start page

  • 30

end page

  • +

volume

  • 24

issue

  • 15

WoS Citations

  • 0

WoS References

  • 0